1,000
Participants
Start Date
June 25, 2025
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2028
Proactive immune tolerance induction
Proactive immune tolerance induction during the first three cycles of chemotherapy, followed by standard treatment in the remaining cycles
Standard Treatment
Standard treatment throughout all chemotherapy cycles
Paclitaxel and carboplatin
A chemotherapy regimen for gynecologic cancers.
Standard premedication (20 mg)
Premedication includes 20 mg of dexamethasone.
Reduced premedication (10 mg)
Premedication includes 20 mg of dexamethasone.
Reduced premedication (5 mg)
Premedication includes 5 mg of dexamethasone.
Seoul National University Hospital, Seoul
Seoul National University Bundang Hospital
OTHER
Seoul National University Boramae Hospital
OTHER
Korea Health Industry Development Institute
OTHER_GOV
Seoul National University Hospital
OTHER